Anne H Larrieux, LPN in Dania, FL - Licensed Practical Nurse

Anne H Larrieux, LPN is a Licensed Practical Nurse based in Dania, Florida. Anne H Larrieux is licensed to practice in Florida (license number 5175393) and her current practice location is 3059 Red Mangrove Ln, Dania, Florida. She can be reached at her office (for appointments etc.) via phone at (954) 925-1997.

NPI number for Anne H Larrieux is 1073772448 and her current mailing address is Po Box 848263, Pembroke Pines, Florida. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1073772448.

Contact Information

	Anne H Larrieux, LPN
	3059 Red Mangrove Ln, Dania, FL 33312-0263
	(954) 925-1997
	Not Available

Provider's Profile

Full Name	Anne H Larrieux
Gender	Female
Speciality	Licensed Practical Nurse
Location	3059 Red Mangrove Ln, Dania, Florida
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1073772448
Provider Enumeration Date: 06/02/2008
Last Update Date: 06/02/2008

Medical Identifiers

Medical identifiers for Anne H Larrieux such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1073772448	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164W00000X	Licensed Practical Nurse	5175393 (Florida)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Anne H Larrieux is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Anne H Larrieux, LPN Po Box 848263, Pembroke Pines, FL 33084-0263 Ph: (954) 925-1997	Anne H Larrieux, LPN 3059 Red Mangrove Ln, Dania, FL 33312-0263 Ph: (954) 925-1997

News Archive

Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ

A new study of women with early stage, localized breast cancer identifies new patterns and risk factors for invasive disease that may influence how patients are treated.

Study focuses on two natural approaches to preventing breast cancer

Preventing cancer requires intimate knowledge of how cancer starts, what causes it to grow and flourish, and how to stop it in its tracks. Sometimes this comes in the form of a vaccine (the HPV vaccine for cervical and head and neck cancers), a screening (a colonoscopy for colorectal cancer) or a blood test (the PSA level test for prostate cancer).

Thiarabine shows promise for rheumatoid arthritis

Access Pharmaceuticals, Inc. announced today new preclinical data demonstrating that thiarabine shows remarkable efficacy in the prevention and treatment of rheumatoid arthritis (RA).

Enzalutamide shows added benefit in prostate cancer patients without visceral metastases

Enzalutamide (trade name: Xtandi) has been approved since June 2013 for men with metastatic prostate cancer in whom the commonly used hormone blockade is no longer effective and who have already been treated with the cytostatic drug docetaxel.

Anne H Larrieux, LPN - Licensed Practical Nurse in Dania, FL